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esponsibility of Xi’Abstract A simple, fast and sensitive capillary electrophoresis (CE) strategy combined with chemilu-
minescence (CL) detection for analysis of oﬂoxacin (OF) enantiomers was established in the present work.
Sulfonated β-cyclodextrin (β-CD) was used as the chiral additive being added into the running buffer of
luminol–diperiodatocuprate (III) (K5[Cu(HIO6)2], DPC) chemiluminescence system. Under the optimum
conditions, the proposed method was successfully applied to separation and analysis of OF enantiomers
with the detection limits (S/N¼3) of 8.0 nM and 7.0 nM for levoﬂoxacin and dextroﬂoxacin, respectively.
The linear ranges were both 0.010–100 μM. The method was utilized for analyzing OF in urine; the
results obtained were satisfactory and recoveries were 89.5–110.8%, which demonstrated the reliability of
this method. This approach can also be further extended to analyze different commercial OF medicines.
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Oﬂoxacin (OF), a quinolones antibiotic, has been widely used due
to its broad-spectrum activity against both Gram-positive and
Gram-negative organisms [1]. Some studies have demonstrated
that the antibacterial activity of the levoﬂoxacin is 8–128 times
higher than that of dextroﬂoxacin and approximately 2 times
higher than that of racemate [2]. Currently, the drug is eithervier B.V. All rights reserved.
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R- and S-enantiomers, or only the S-isomer. Therefore, studies on
the separation of racemic oﬂoxacin and its application in pharma-
ceutical formulations are important.
Nowadays, several chiral extractants have been reported for the
enantioselective analysis of OF. In the work of Fang et al. [3],
cyclodextrin derivative was successfully applied for the separation of
OF enantiomer. Li et al. [4] used natural biomacromolecules including
BSA and DNA for enantioseparation of OF. Fu et al. [5] utilized
functional Cu(II)-coordinated G-rich oligonucleotides for enantiose-
lective separation of chiral OF. Among these chiral selectors, the CD
was the most used in varieties of enantioselective analysis.
β-CD is the most popular chiral selector in the cyclodextrins
[6,7]. However, the poor water solubility and the lack of functional
groups limit the optimization of separation selectivity for enantio-
mers [2]. Chemical modiﬁcation of β-CD could increase its
solubility and the enantioseparation capacity. Recently, several
studies about the use of charged β-CD derivatives [8–12] such as
sulfated [9,10], hydroxypropyl [11] and methoxyethylammonium
[12] β-CD as chiral selectors have been published. These CDs
have been successfully employed in the enantioseparation of both
basic and acidic chiral compounds. Sulfated β-CD is usually
employed due to its relatively simple synthesis process than other
β-CD derivatives. Therefore, in the present paper, sulfated β-CD
was employed for the ﬁrst time as a chiral selector in chiral
separation of OF enantiomers.
CL detection was combined with CE separation, due to its
distinguished sensitivity and inexpensive instrumentation. Diperio-
datocuprate (III) (K5[Cu(HIO6)2], DPC), is a transition metal chelate
at an unstable high oxidation state, just as our previous work [13,14]
described in detail, and can react with luminol to generate a CL
emission in a basic medium. Moreover, OF could greatly enhance
this CL reaction to produce very strong CL signal. This CL system
was utilized to develop a rapid and sensitive CE–CL method for the
determination of OF. Using sulfonated β-CD as chiral additive, this
method could be successfully applied for the separation and
determination of OF enantiomers in urine samples.2. Materials and methods
2.1. Chemicals and materials
Potassium persulfate (K2S2O8), cupric sulfate (CuSO4  5H2O),
potassium hydroxide (KOH), and potassium periodate (KIO4)
were purchased from Kelong Chemical Reagent Plant (Chengdu,
China). Luminol and oﬂoxacin were obtained from Sigma-Aldrich
(St. Louis, USA). Levoﬂoxacin was provided by the National
Institutes for Food and Drug Control (Beijing, China). Dextro-
ﬂoxacin was purchased from LKT Laboratories, Inc. (St. Paul,
USA). Sulfated-β-CD (M¼1444) was purchased from Binzhou
Zhiyuan Bio-Technology Co., Ltd. (Shandong, China). Fused-
silica capillary was provided by Yongnian Optical Fiber Co., Ltd.
(Hebei, China). Phosphate buffer was prepared by dissolving
0.03 g of NaH2PO4 in 100 mL water, and the pH was adjusted
with 1.0 M NaOH. The luminol stock solution at 10.0 mM was
prepared by dissolving 0.18 g of luminol in 100 mL of 0.10 M
NaOH solutions, and stored in the refrigerator at 4 1C. All
solutions were prepared with ultra-pure water (18.2 MΩ) treated
with ELGA PURELAB classic system (Veolia Water Solutions &
Technologies Co., Ltd., London, UK). Early morning urine
samples were collected from three healthy volunteers.2.2. Synthesis of DPC
The DPC stock solution at 10.0 mM was prepared by oxidizing Cu
(II) in a strong alkaline medium according to the previously
reported method [15]. In brief, KIO4 (0.23 g), CuSO4  5H2O
(0.12 g), K2S2O8 (0.14 g) and KOH (0.80 g) were mixed and
dissolved in 30 mL of water. The solution was heated until boiling
and kept at that temperature for about 20 min with constant
stirring. The dark red product solution was then cooled to room
temperature and diluted to 50 mL with water. The obtained DPC
solution was stored in the refrigerator at 4 1C, and could be kept
stable for no less than 5 months. The ultraviolet/visible absorbance
spectrum of the chelate exhibited a broad band at 415 nm.
2.3. Apparatus and procedures
All the CE–CL experiments were performed on a home-assembled
apparatus, which was constructed in a post-column ﬂow-through
detection mode [11]. Teﬂon tubes (0.80 mm I.D.) were used to
connect all the components in the ﬂow system. A fused-silica capillary
(60 cm 75 mm I.D.) was used for CE separation. In this study, the
new capillaries were rinsed sequentially with 1.0 M NaOH solution
for 30 min and water for another 30 min prior to the ﬁrst use. Between
two consecutive injections, the capillary was ﬂushed sequentially with
0.10 M NaOH solution, water and RB for 2 min each. A 0.50-cm
polyimide coating section at one tip of the capillary column was
burned and removed. The burned tip of the capillary was directly
inserted into an optical glass tube (3.0 cm 1.0 mm I.D.) acting as the
CL detection window. The CL detection window was located above a
photomultiplier (PMT) operated at 800 V for performing CL signal
collection. Both the detection window and the PMT were sealed in a
dark box to avoid interference from the external light.
The RB used for CE separation was 2.0 mM phosphate buffer
(pH 4.0) containing 0.10 mM luminol and 3.0 mg/mL sulfated-β-
CD, and the separation voltage was 12 kV. The solution of
0.10 mM DPC in 40 mM NaOH was siphoned into the detection
window with an altitude difference of 25 cm, to trigger the CL
reaction. After a stable baseline was obtained, the sample was
loaded by gravity injection for 15 s at an altitude difference of
15 cm. The peak height of the electropherogram was applied as the
quantitative parameter to evaluate the level of OF. Data acquisition
and treatment were performed using an IFFM software package
(Remex, Xi’an, China).
2.4. Urine sample preparation
A 500-μL urine sample in a 3.0-mL centrifuge tube was mixed
with 1.0 mL of acetonitrile and shaken vigorously for 2 min to
precipitate proteins. After centrifuging at 10,000 rpm for 10 min,
the supernatant was transferred into a 1.5-mL vial and dried with a
gentle nitrogen stream. The residue was re-dissolved in 500 μL of
water. The processed samples were diluted with water if necessary
after being ﬁltered through a 0.22-μm membrane ﬁlter.3. Results and discussion
3.1. Kinetic characteristic of OF–luminol–DPC CL reaction
The preliminary experiment demonstrated that luminol could be
oxidized by DPC to produce CL emission in alkaline solution, and
H.-Y. Xie et al.414this CL emission could be greatly enhanced in the reaction in the
presence of OF. The kinetic characteristics of both DPC–luminol–
OF and DPC–luminol CL reactions were tested by a static mode,
and the typical response curves (CL intensity versus times) are
shown in Fig. 1. It was found that the CL emission only took the
maximum of 0.3 s after DPC was injected into the mixture of
luminol and OF. Such a rapid kinetic characteristic for DPC–
luminol–OF CL reaction was very helpful in obtaining a high
sensitivity since the contacting time of DPC and the efﬂuent from
the capillary was very short in the ﬂow-through detection interface.Fig. 2 Electropherograms for analysis of 40 μΜ OF. Running buffer:
2.0 mM phosphate buffer (pH 4.0) containing 0.10 mM luminol and
3.0 mg/mL β-CD (A), or 3.0 mg/mL tosyl-β-CD (B), or 3.0 mg/mL
sulfated-β-CD (C). The solution of 0.10 mM DPC in 40 mM NaOH
was siphoned into the detection window with an altitude difference of
25 cm. 1¼dextroﬂoxacin, 2¼ levoﬂoxacin.3.2. Chiral separation of OFs
CDs have been successfully utilized as chiral selectors in CE for
enantiomeric separations of chiral drugs and other compounds. In this
method, β-CD, tosyl-β-CD and sulfated-β-CD were tested for the
enantiomeric separation of OFs. β-CD and tosyl-β-CD showed limited
solubility and slight interaction with the analytes. The electrophero-
grams obtained from the three chiral selectors are shown in Fig. 2.
A satisfactory chiral recognition was achieved when sulfated-β-CD
was chosen as the chiral selector. The concentration of sulfated-β-CD
was a key factor inﬂuencing the chiral resolution of OFs. The highest
signal intensity and the best peak shape were obtained when the
concentration of sulfated-β-CD was 3.0 mg/mL.3.3. Condition optimization
To obtain a good analytical performance, we investigated the
dependence of the column efﬁciency and the relative CL intensity
on the RB conditions. The results showed that a basic RB led to a
very poor chiral separation when sulfated-β-CD was used as the
chiral selector. Phosphate buffer at pH 4.0 (2.0 mM) was ﬁnally
chosen as the optimal RB because it provided satisfactory chiral
recognition and an acceptable relative CL signal intensity. The
inﬂuence of the luminol concentration in RB was investigated in
the range of 0.02–0.50 mM, and the optimum concentration for the
CL reaction was found to be 0.10 mM.Fig. 1 Kinetic curves for (A and B) luminol–DPC–OF and (C) luminol–
DPC CL systems. 100 mL DPC solution (5.0 μM) was injected into a
mixture of 0.50 mL of 1.0 μM luminol (in 40 mM NaOH), 10 μL of
3.0 mg/mL sulfated-β-CD and 1.0 mL of 5.0 μM (A) levoﬂoxacin or (B)
dextroﬂoxacin. (C) 100 mL DPC solution (5.0 μM) was injected into a
mixture of 0.50 mL of 1.0 μM luminol (in 40 mM NaOH), 10 μL of
3.0 mg/mL sulfated-β-CD and 1.0 mL of water.DPC was used as an efﬁcient oxidant in this CL reaction, and
showed a great effect on the generation of CL signal. The effect of
DPC concentration on the CL signal was studied in the range of
0.025–0.40 mM. As shown in Fig. 3A, the CL signal increased
with the concentration of DPC, and reached the maximum when
DPC was 0.10 mM. The decreased CL intensity at higher DPC
concentration could be attributed to the self-absorption of the DPC
solution, since DPC showed a peak absorbance at 415 nm, which
was very near the maximum emission wavelength of luminol
(425 nm). NaOH provided the required alkaline environment in
this CL system. As shown in Fig. 3B, the effect of the NaOH
concentration on the relative CL intensity was investigated in the
range of 10–60 mM. The results indicated that the maximal
relative CL intensity was reached when the NaOH concentration
was 40 mM; however, higher concentration of NaOH also
decreased the CL signal. Thus, 40 mM was chosen as the optimal
NaOH concentration.
In order to avoid the electrical discrimination resulting from the
electromigration injection, the sample was loaded into the capillary
column by an altitude difference. The increased loading time and
height difference led to a high CL signal owing to a large sample
loading amount, which also resulted in a broadened peak and a
decreased resolution. After careful investigation, the loading time
and the height difference were chosen to be 15 s and 20 cm,
respectively.
3.4. Analytical performance
Under the optimal conditions, a series of levoﬂoxacin and
dextroﬂoxacin standard samples at different concentrations were
assayed using the proposed CE–CL method. The linear ranges
were both 0.010–100 μM, with the detection limits (S/N¼3) of
8.0 nM and 7.0 nM for levoﬂoxacin and dextroﬂoxacin, respec-
tively. The correlation coefﬁcients for levoﬂoxacin and dextro-
ﬂoxacin were 0.9912 and 0.9917, respectively. The detection
limits of levoﬂoxacin and dextroﬂoxacin were about 100 times
lower than those obtained with the previously reported HPLC
combined with UV–vis absorbance detection [16]. The whole
chiral separation process could be completed within 9 min with the
Fig. 3 Effects of the concentration of (A) DPC and (B) NaOH on the CL signal from (■) levoﬂoxacin and (▲) dextroﬂoxacin at 10 μM. All other
conditions were the selected optimal condition (n¼5).
Fig. 4 Electropherograms for analysis of (A) blank urine sample and
(B) urine sample spiked with OFs at 40 μM. All the conditions were
the selected optimal conditions. 1¼dextroﬂoxacin, 2¼ levoﬂoxacin.
Table 1 The results of urine analysis and the recovery
studies of OF (n¼5).
Samples Added (μM) Found (μM) Recovery (%)
Urine 1 20.0 18.570.8 92.5
40.0 41.572.3 103.8
70.0 74.475.6 106.3
Urine 2 20.0 17.970.9 89.5
40.0 44.372.8 110.8
70.0 72.276.5 103.1
Urine 3 20.0 20.571.1 102.5
40.0 38.272.3 95.5
70.0 69.775.8 99.6
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and levoﬂoxacin, respectively. The reproducibility was assessed
by intra- and inter-day RSDs for 12 replicate determinations of
levoﬂoxacin and dextroﬂoxacin standard samples at 10 μM. The
intra- and inter-day RSDs for CL signals were 6.2% and 7.1%, and
those for migration times were 4.8% and 5.2%, respectively.
3.5. Determination of OF in human urine
The proposed strategy was also utilized for the detection of OF in
three human urine samples to evaluate its potential application
value in pharmacokinetical investigation. The research involving
samples from human has been approved of by the local research
ethics committee. The electropherograms of the urine samples areshown in Fig. 4. The three urine samples were also spiked with OF
standards at different concentrations and assayed using the
proposed method. Recoveries from 89.5% to 110.8% were
obtained as shown in Table 1. To assess the repeatability, ﬁve
consecutive determinations of OF in urine samples were per-
formed. The RSDs for the migration time, the peak heights and
recoveries were less than 6.4%, 7.3% and 8.3%, respectively.4. Conclusion
OF enantiomers were successfully separated by the established
CE–CL strategy. The presence of sulfated-β-CD in the running
buffer has played an important role in enhancing resolution
between enantiomers. DPC, a transition metal chelate at unstable
high oxidation state, was synthesized in a strong basic solution,
and acted as the oxidant in this novel CL reaction. The method
was applied in spiked urine samples. Sulfated-β-CD as an additive
of chiral separation provides a new approach for the separation of
H.-Y. Xie et al.416chiral drugs which are difﬁcult to be separated under the common
electrophoresis conditions. Finally, the proposed method could be
applied to analyze commercial oﬂoxacin medicines. This study
exhibits the potential for the separation and determination of other
chiral medicines by the CE–CL method.
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